Skip to main content
. 2018 Apr;23(2):129–134. doi: 10.17712/nsj.2018.2.20170434

Table 3.

Adverse events during 12 month study.

Adverse events n (%)
Upper Respiratory tract Infection 20 (3.33)
Headache 10 (16.66)
Urinary Tract Infection 8 (13.33)
Menstrual irregularity 5 (8.33)
Pneumonia 3 (5.0)
Dyspnea 3 (5.0)
Anxiety 2 (3.33)
Influenza 1 (1.66)
Dyspepsia 1 (1.66)
Restless Leg Syndrome 1 (1.66)
Depression 1 (1.66)